-transparent.png){kind=logo}
Plasma haloperidol levels were monitored in three schizophrenic patients when carbamazepine was either added or discontinued. The percent decrease in plasma haloperidol levels due to concomitant carbamazepine therapy was between 59% and 61%. The effects of carbamazepine on plasma haloperidol levels were noted to occur in 2 to 3 weeks. Although no adverse effects occurred in the patients during therapy, careful monitoring of clinical symptoms and plasma haloperidol levels is recommended.
Related Publications
M W Jann, and
L Ereshefsky, and
S R Saklad, and
D R Seidel, and
C M Davis, and
N R Burch, and
C L Bowden
June 1995,
Clinical neuropharmacology,
M W Jann, and
L Ereshefsky, and
S R Saklad, and
D R Seidel, and
C M Davis, and
N R Burch, and
C L Bowden
August 1999,
Journal of clinical psychopharmacology,
M W Jann, and
L Ereshefsky, and
S R Saklad, and
D R Seidel, and
C M Davis, and
N R Burch, and
C L Bowden
May 1986,
The American journal of psychiatry,
M W Jann, and
L Ereshefsky, and
S R Saklad, and
D R Seidel, and
C M Davis, and
N R Burch, and
C L Bowden
January 1996,
The American journal of psychiatry,
M W Jann, and
L Ereshefsky, and
S R Saklad, and
D R Seidel, and
C M Davis, and
N R Burch, and
C L Bowden
July 1981,
Acta physiologica Scandinavica,
M W Jann, and
L Ereshefsky, and
S R Saklad, and
D R Seidel, and
C M Davis, and
N R Burch, and
C L Bowden
June 2007,
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society,
M W Jann, and
L Ereshefsky, and
S R Saklad, and
D R Seidel, and
C M Davis, and
N R Burch, and
C L Bowden
May 1983,
Acta paediatrica Scandinavica,
M W Jann, and
L Ereshefsky, and
S R Saklad, and
D R Seidel, and
C M Davis, and
N R Burch, and
C L Bowden
January 1993,
Journal of psychiatric research,
M W Jann, and
L Ereshefsky, and
S R Saklad, and
D R Seidel, and
C M Davis, and
N R Burch, and
C L Bowden
February 1985,
Biological psychiatry,
M W Jann, and
L Ereshefsky, and
S R Saklad, and
D R Seidel, and
C M Davis, and
N R Burch, and
C L Bowden
January 1993,
The American journal of psychiatry,
